Home>Supplier>Wuhan Win Yuanbei Trading Co., Ltd.>(+/-)-Cloprostenol sodium salt hydrate

Wuhan Win Yuanbei Trading Co., Ltd.

Wuhan Win Yuanbei Trading Co., Ltd.

Certified Store
Trader/Contractor/Dealer
China Hubei Wuhan
869523959@qq.com
13349903920
13349903920

Catalog No. : khg1

(+/-)-Cloprostenol sodium salt hydrate

  • 55028-72-3
  • 100g
  • 99%
Packing :
More
Price :
US $233.33 /100g MOQ 1g
  • Product Details & Description
  • MSDS

Product Info

Compound (+/-)-Cloprostenol sodium salt hydrate
CAS No. 55028-72-3 Catalog No. khg1 Brand
Purity 99% Packing 100g Grade
Lead Time Origin Loading Port

PropertiesMore

Boiling Point 628ºC at 760 mmHg
Storage Condition -20ºC
Appearance & Physical State white to almost white, hygroscopic powder
Flash Point 333.6ºC
Melting Point 68-70ºC

Description

CBNumber CB7699245

Cloprostenol sodium

MF C22H28ClO6.Na

MW 446.9

CAS 55028-72-3

MOL Mol file


The supplier has not provide MSDS, The information below is provided by MOLBASE Encyclopedia for your reference.

MSDS


Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
  Product identifiers
    Product name        : (+/-)-Cloprostenol sodium salt hydrate    
  

Section 2. HAZARDS IDENTIFICATION
  Classification of the substance or mixture
  Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
    Acute toxicity, Oral (Category 4)
    Skin irritation (Category 2)
    Eye irritation (Category 2)
    Reproductive toxicity (Category 2)
    Specific target organ toxicity - single exposure (Category 3)
  Classification according to EU Directives 67/548/EEC or 1999/45/EC
    May impair fertility. Harmful if swallowed. Irritating to eyes, respiratory system and skin.
  Label elements
  Labelling according Regulation (EC) No 1272/2008 [CLP]
    Pictogram
    Signal word        Warning    
    Hazard statement(s)
    Harmful if swallowed.
    Causes skin irritation.
    Causes serious eye irritation.
    May cause respiratory irritation.
    Suspected of damaging fertility or the unborn child.
    Precautionary statement(s)
    Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
    Use personal protective equipment as required.
    P305 + P351 + P338        IF IN EYES: Rinse cautiously with water for several minutes. Remove    
    contact lenses, if present and easy to do. Continue rinsing.
    Supplemental Hazard        none    
    Statements
  According to European Directive 67/548/EEC as amended.
    Hazard symbol(s)
    R-phrase(s)
    R60        May impair fertility.    
    R22        Also harmful if swallowed.    
    R36/37/38        Irritating to eyes, respiratory system and skin.    
    S-phrase(s)
    S26        In case of contact with eyes, rinse immediately with plenty of water and    
    seek medical advice.
    S36/37/39        Wear suitable protective clothing, gloves and eye/face protection.    
    S45        In case of accident or if you feel unwell, seek medical advice immediately    
    (show the label where possible).
    Restricted to professional users.
  Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
  Substances
    Synonyms        : (+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-    
    tetranorprosta-5Z,13E-dien-1-oic acidsodium salthydrate
    Formula        : C22H28ClNaO6 · xH2O    
    Molecular Weight        : 446,90 g/mol    
    Component        Concentration    
  Sodium [1α(Z),2β(1E,3R*),3α,5α]-(+/-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-
  dihydroxycyclopentyl]hept-5-enoate hydrate
    EC-No.        259-439-3        -    

Section 4. FIRST AID MEASURES
  Description of first aid measures
  General advice
    Consult a physician. Show this safety data sheet to the doctor in attendance.
  If inhaled
    If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
  In case of skin contact
    Wash off with soap and plenty of water. Consult a physician.
  In case of eye contact
    Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
  If swallowed
    Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
  Most important symptoms and effects, both acute and delayed
    Vomiting, Nausea, An oxytocic: induces contraction of uterine smooth muscle, transient bronchospasm,
    wheezing
  Indication of any immediate medical attention and special treatment needed
    no data available

Section 5. FIREFIGHTING MEASURES
  Extinguishing media
  Suitable extinguishing media
    Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
  Special hazards arising from the substance or mixture
    Carbon oxides, Hydrogen chloride gas, Sodium oxides
  Advice for firefighters
    Wear self contained breathing apparatus for fire fighting if necessary.
  Further information
    no data available

Section 6. ACCIDENTAL RELEASE MEASURES
  Personal precautions, protective equipment and emergency procedures
    Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
    adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
  Environmental precautions
    Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
  Methods and materials for containment and cleaning up
    Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
    containers for disposal.
  Reference to other sections
    For disposal see section 13.

Section 7. HANDLING AND STORAGE
  Precautions for safe handling
    Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
    Provide appropriate exhaust ventilation at places where dust is formed.
  Conditions for safe storage, including any incompatibilities
    Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
    Recommended storage temperature: -20 °C
    Store with desiccant.
  Specific end uses
    no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
  Control parameters
  Components with workplace control parameters
  Exposure controls
  Appropriate engineering controls
    Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
    at the end of workday.
  Personal protective equipment
  Eye/face protection
    Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
    and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
  Skin protection
    Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
    (without touching glove's outer surface) to avoid skin contact with this product. Dispose of
    contaminated gloves after use in accordance with applicable laws and good laboratory practices.
    Wash and dry hands.
    The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
    the standard EN 374 derived from it.
  Body Protection
    Complete suit protecting against chemicals, The type of protective equipment must be selected
    according to the concentration and amount of the dangerous substance at the specific workplace.
  Respiratory protection
    Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
    respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
    controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
    respirators and components tested and approved under appropriate government standards such
    as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
  Information on basic physical and chemical properties
    a) Appearance        Form: solid    
    b) Odour        no data available    
    c) Odour Threshold        no data available    
    d) pH        no data available    
    e) Melting point/freezing        Melting point/range: 68 - 70 °C    
    point
    f) Initial boiling point and no data available
    boiling range
    g) Flash point        no data available    
    h) Evaporation rate        no data available    
    i) Flammability (solid, gas) no data available
    j) Upper/lower        no data available    
    flammability or
    explosive limits
    k) Vapour pressure        no data available    
    l) Vapour density        no data available    
    m) Relative density        no data available    
    n) Water solubility        no data available    
    o) Partition coefficient: n- no data available
    octanol/water
    p) Autoignition        no data available    
    temperature
    q) Decomposition        no data available    
    temperature
    r) Viscosity        no data available    
    s) Explosive properties        no data available    
    t) Oxidizing properties        no data available    
  Other safety information
    no data available

Section 10. STABILITY AND REACTIVITY
  Reactivity
    no data available
  Chemical stability
    no data available
  Possibility of hazardous reactions
    no data available
  Conditions to avoid
    no data available
  Incompatible materials
    Oxidizing agents
  Hazardous decomposition products
    Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
  Information on toxicological effects
  Acute toxicity
    no data available
    Inhalation: no data available
  Skin corrosion/irritation
    no data available
  Serious eye damage/eye irritation
    no data available
  Respiratory or skin sensitization
    no data available
  Germ cell mutagenicity
    no data available
  Carcinogenicity
    no data available
    IARC:        No component of this product present at levels greater than or equal to 0.1% is identified as    
    probable, possible or confirmed human carcinogen by IARC.
  Reproductive toxicity
    Suspected human reproductive toxicant
  Specific target organ toxicity - single exposure
    May cause respiratory irritation.
  Specific target organ toxicity - repeated exposure
    no data available
  Aspiration hazard
    no data available
  Potential health effects
  Inhalation        May be harmful if inhaled. Causes respiratory tract irritation.    
  Ingestion        Harmful if swallowed.    
  Skin
    May be harmful if absorbed through skin. Causes skin irritation.
  Eyes        Causes serious eye irritation.    
  Signs and Symptoms of Exposure
    Vomiting, Nausea, An oxytocic: induces contraction of uterine smooth muscle, transient bronchospasm,
    wheezing
  Additional Information
    RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
  Toxicity
    no data available
  Persistence and degradability
    no data available
  Bioaccumulative potential
    no data available
  Mobility in soil
    no data available
  Results of PBT and vPvB assessment
    no data available
  Other adverse effects
    no data available

Section 13. DISPOSAL CONSIDERATIONS
  Waste treatment methods
  Product
    Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
    with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
  Contaminated packaging
    Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
  UN number
    ADR/RID: -        IMDG: -        IATA: -    
  UN proper shipping name
    ADR/RID: Not dangerous goods
    IMDG: Not dangerous goods
    IATA:        Not dangerous goods    
  Transport hazard class(es)
    ADR/RID: -        IMDG: -        IATA: -    
  Packaging group
    ADR/RID: -        IMDG: -        IATA: -    
  Environmental hazards
    ADR/RID: no        IMDG Marine pollutant: no        IATA: no    
  Special precautions for user
    no data available

Section 15. REGULATORY INFORMATION
    This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
  Safety, health and environmental regulations/legislation specific for the substance or mixture
    no data available
  Chemical Safety Assessment
    no data available


SECTION 16 - ADDITIONAL INFORMATION
N/A

Request For Quotation

Product

(+/-)-Cloprostenol sodium salt hydrate

Cas No

55028-72-3

*Purity
*Quantity
*Valid for
*Shipping To
Contact Person
*Email
*Company/Institute
Notes

I would like to have suppliers recommended by MOLBASE.

I agree to share my contact information to the supplier(s).

Other Supplier Reference

Product Name Purity Packing Lead Time Country Store Name Details
(±)- CLOPROSTENOL SODIUM SALT 99.0-100.5% 20kg IN STOCK Switzerland,Zurich
DKSH International Ltd.
Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 99% 1g 1Day (s) China,Hubei Hubei Kang Baotai Fine Chemical Co., Ltd. Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 99% 1kg 14Day (s) China,Hainan Haikou Zhuoyoute Pharmaceutical Co. Ltd. Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 99% 100g,25g 3 spec IN STOCK China,Hubei Huatesheng Biotechnology (Wuhan) Co., Ltd. Request For Quotation
Cloprostenol?Sodium 98% 1kg,100kg 3 spec 14Day (s) China,Zhejiang
Hangzhou J&H Chemical Co., Ltd.
Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 98% 1kg 14Day (s) China,Shanghai
Shanghai Caiyu Wen Biochemical Technology Co., Ltd.
Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 99% 1g 5Day (s) China,Shaanxi Baoji Guokang Bio-Technology Co., Ltd Request For Quotation
(+/-)-Cloprostenol sodium salt hydrate 98% 1g 14Day (s) China,Shanghai Shanghai Fanqin Pharmaceutical Technology Co., Ltd. Request For Quotation
5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-,sodium salt (1:1), (5Z)-rel- 99% 25kg,1kg 7Day (s) China,Henan
Henan Tianfu Chemical Co.,Ltd
Request For Quotation
(±)-Cloprostenol sodium 98% 1g,1kg 3 spec 3Day (s) China,Hubei
Wuhan Yongsheng Biological Technology Co., Ltd.
Request For Quotation
View All Suppliers